Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Key innovations awards recognize PENTAX Medical for new product developments

PENTAX Medical is pleased to announce that the innovation within its new product developments has been recognized by two key awards.

From PENTAX Medical Company 6 Jul 2018

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

In preclinical experiments, Laurie Harrington, Ph.D., and colleagues at the University of Alabama at Birmingham have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease.

27 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its program to develop a defined bacterial product for ulcerative colitis (UC). Financial details have not been disclosed.

19 Jun 2018

Faeces donors do it out of willingness not money - study

Healthy adults who have a good constitution and have a healthy heart are being called forth to donate samples of their faeces to science. The donors would be screened rigorously before they can be included and would be compensated modestly for their donations say researchers.

6 Jun 2018

Cedars-Sinai study identifies gut gas associated with diarrhea

Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses - small intestine bacterial overgrowth and irritable bowel syndrome.

6 Jun 2018

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.

4 Jun 2018

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

31 May 2018

Researchers trigger natural defense mechanism to alleviate intestinal inflammation

Treating inflammatory diseases of the bowel is extremely challenging: Genes, gut microbes and disrupted immune function all contribute.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Researchers reveal potent new mechanism of action for treatment of IBD

Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.

25 May 2018

Celltrion Healthcare advocates early introduction of biologics for patients to improve clinical outcomes

At the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes.

22 May 2018

Study: Psoriasis patients taking Humira show no change in aortic inflammation

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation – a key marker of future risk of major cardiovascular events – unlike other antibodies that target different aspects of the immune system.

18 May 2018

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.

16 May 2018

Study points to new treatments for incurable bowel conditions

Treatments for incurable bowel conditions may be a step closer following the discovery of a key molecule associated with disease flare-ups.

3 May 2018

Single FMT enema produces sustained and significant improvements in cognitive function

A single treatment using an optimized, targeted form of faecal microbiota transplantation (FMT) produces sustained clinical and cognitive improvements, according to the results of a long-term follow-up of patients with liver cirrhosis and hepatic encephalopathy (HE) who had participated in a short-term study.

16 Apr 2018

Analysis does not reveal consistent link between NSAIDs use and exacerbation of inflammatory bowel disease

Contrary to generally accepted belief, a recent review and analysis of published studies did not reveal a consistent association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and exacerbation of Crohn's disease and ulcerative colitis.

5 Apr 2018

University Hospitals study suggests strong connection between IBD and heart attacks

University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.

6 Mar 2018

IQuity launches pioneering RNA-based blood test to diagnose fibromyalgia

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome.

5 Mar 2018

Inflammatory bowel disease linked to elevated risk of heart attack

An analysis of medical-record data from more than 17.5 million patients found that people with inflammatory bowel disease (IBD) are at elevated risk for a heart attack, regardless of whether or not they have traditional risk factors for heart disease such as high cholesterol, high blood pressure and smoking.

1 Mar 2018

Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Key innovations awards recognize PENTAX Medical for new product developments

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Faeces donors do it out of willingness not money - study

Cedars-Sinai study identifies gut gas associated with diarrhea

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

Researchers trigger natural defense mechanism to alleviate intestinal inflammation

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Researchers reveal potent new mechanism of action for treatment of IBD

Celltrion Healthcare advocates early introduction of biologics for patients to improve clinical outcomes

Study: Psoriasis patients taking Humira show no change in aortic inflammation

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Study points to new treatments for incurable bowel conditions

Single FMT enema produces sustained and significant improvements in cognitive function

Analysis does not reveal consistent link between NSAIDs use and exacerbation of inflammatory bowel disease

University Hospitals study suggests strong connection between IBD and heart attacks

IQuity launches pioneering RNA-based blood test to diagnose fibromyalgia

Inflammatory bowel disease linked to elevated risk of heart attack

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in